Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Theranostic Biomarkers for Schizophrenia
Matea Nikolac Perković, Gordana Nedić Erjavec, Dubravka Švob Štrac, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 4, pp. 733-733
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: A cross-sectional study
Yang Shen, Jintian Xu, Zhiyong Li, et al.
Schizophrenia Research (2018) Vol. 197, pp. 470-477
Closed Access | Times Cited: 286
Cytokines dysregulation in schizophrenia: A systematic review of psychoneuroimmune relationship
Daniela Rodrigues-Amorím, Tania Rivera‐Baltanás, Carlos Spuch, et al.
Schizophrenia Research (2017) Vol. 197, pp. 19-33
Closed Access | Times Cited: 105
Advanced EEG-based learning approaches to predict schizophrenia: Promises and pitfalls
Carla Barros, Carlos A. Silva, Ana P. Pinheiro
Artificial Intelligence in Medicine (2021) Vol. 114, pp. 102039-102039
Open Access | Times Cited: 79
Constructing the Immune Signature of Schizophrenia for Clinical Use and Research; An Integrative Review Translating Descriptives Into Diagnostics
Rune A. Kroken, Iris E. Sommer, Vidar M. Steen, et al.
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 76
EEG microstates as biomarker for psychosis in ultra-high-risk patients
Renate de Bock, Amatya Mackintosh, Franziska Maier, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 73
Reduced neonatal brain-derived neurotrophic factor is associated with autism spectrum disorders
Kristin Skogstrand, Christian M. Hagen, Nis Borbye‐Lorenzen, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Short overview on metabolomic approach and redox changes in psychiatric disorders
Gordana Nedić Erjavec, Marcela Konjevod, Matea Nikolac Perković, et al.
Redox Biology (2017) Vol. 14, pp. 178-186
Open Access | Times Cited: 64
DNA Methylation and Schizophrenia: Current Literature and Future Perspective
Thabo Magwai, Khanyiso Bright Shangase, Fredrick Otieno Oginga, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2890-2890
Open Access | Times Cited: 41
Comparison of gut microbiome profile in patients with schizophrenia and healthy controls - A plausible non-invasive biomarker?
Kuppan Gokulakrishnan, Joyappa Nikhil, Biju Viswanath, et al.
Journal of Psychiatric Research (2023) Vol. 162, pp. 140-149
Closed Access | Times Cited: 16
The neurobiological hypothesis of neurotrophins in the pathophysiology of schizophrenia: A meta-analysis
Daniela Rodrigues-Amorím, Tania Rivera‐Baltanás, João M. Bessa, et al.
Journal of Psychiatric Research (2018) Vol. 106, pp. 43-53
Closed Access | Times Cited: 56
Testing Psychosis Phenotypes From Bipolar–Schizophrenia Network for Intermediate Phenotypes for Clinical Application: Biotype Characteristics and Targets
Brett A. Clementz, Rebekah Trotti, Godfrey D. Pearlson, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2020) Vol. 5, Iss. 8, pp. 808-818
Closed Access | Times Cited: 44
Neural cell‐derived plasma exosome protein abnormalities implicate mitochondrial impairment in first episodes of psychosis
Edward J. Goetzl, Vinod H. Srihari, Sinan Gülöksüz, et al.
The FASEB Journal (2021) Vol. 35, Iss. 2
Open Access | Times Cited: 35
Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments
Antón L. Martínez, José Brea, Sara Rico, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9905-9905
Open Access | Times Cited: 33
Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system
Vertika Gautam, Anand Gaurav, Neeraj Masand, et al.
Molecular Diversity (2022) Vol. 27, Iss. 2, pp. 959-985
Closed Access | Times Cited: 23
Vagus nerve stimulation for epilepsy: A narrative review of factors predictive of response
Harry Clifford, Menaka Pasangy Paranathala, Yujiang Wang, et al.
Epilepsia (2024)
Open Access | Times Cited: 5
Metabolomic and glycomic findings in posttraumatic stress disorder
Marcela Konjevod, Lucija Tudor, Dubravka Švob Štrac, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2018) Vol. 88, pp. 181-193
Open Access | Times Cited: 45
Saccadic eye movements in different dimensions of schizophrenia and in clinical high-risk state for psychosis
Ilya Obyedkov, Maryna Skuhareuskaya, Oleg Skugarevsky, et al.
BMC Psychiatry (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 36
Bioinformatics analysis of long non-coding RNA-associated competing endogenous RNA network in schizophrenia
Hani Sabaie, Madiheh Mazaheri Moghaddam, Marziyeh Mazaheri Moghaddam, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 31
Pharmaco-EEG of antipsychotic treatment response: a systematic review
Marco De Pieri, Vincent Rochas, Michel Sabé, et al.
Schizophrenia (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Theta-phase gamma-amplitude coupling as a neurophysiological marker in neuroleptic-naïve schizophrenia
Geun Hui Won, Jun Won Kim, Tae Young Choi, et al.
Psychiatry Research (2017) Vol. 260, pp. 406-411
Closed Access | Times Cited: 35
Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia
Marina Šagud, Lucija Tudor, Suzana Uzun, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 33
Neuropeptides and oligopeptidases in schizophrenia
Benjamín Rodríguez, João V. Nani, Priscila G.C. Almeida, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 108, pp. 679-693
Closed Access | Times Cited: 32
Oxidative Stress Biomarkers as a Predictor of Stage Illness and Clinical Course of Schizophrenia
Dariusz Juchnowicz, Michał Dzikowski, Joanna Róg, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 23
Salivary cortisol in Schizophrenia: a selective review and meta-analysis of controlled studies of the past decade
Walter Paganin, Sabrina Signorini
Biomarkers in Neuropsychiatry (2024) Vol. 11, pp. 100098-100098
Open Access | Times Cited: 3
Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways
Daniela Rodrigues-Amorím, Tania Rivera‐Baltanás, María del Carmen Vallejo-Curto, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top